Prognostic factors for resectable pancreatic adenocarcinoma

J Visc Surg. 2011 Sep;148(4):e232-43. doi: 10.1016/j.jviscsurg.2011.07.007. Epub 2011 Sep 15.


Pancreatic ductal adenocarcinoma represents 90% of pancreatic cancers and the fifth cause of cancer death in Western countries. Overall survival rate at 5 years is less than 5%. Surgical resection is still the only treatment providing prolonged survival but, even after a curative resection, 5-year survival rates are low. However, some patients have a slower tumor progression and increased median survival due to treatment advances and better patient selection. The objective of this review is to analyze the prognostic factors related to patient, treatment and tumor, to identify those associated with better long-term survival after resection of pancreatic adenocarcinoma.

Publication types

  • Review

MeSH terms

  • Carcinoma, Pancreatic Ductal / surgery*
  • Humans
  • Pancreatectomy / methods*
  • Pancreatic Neoplasms / surgery*
  • Prognosis
  • Risk Factors
  • Survival Rate